DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
Norketamine is an investigational drug.
There have been 8 clinical trials for Norketamine. The most recent clinical trial was a Phase 1 trial, which was initiated on February 1st 2016.
The most common disease conditions in clinical trials are Pain, Postoperative, Chronic Pain, and Depressive Disorder, Major. The leading clinical trial sponsors are University of Texas Southwestern Medical Center, Columbia University, and Arkansas Children's Hospital Research Institute.
There are eleven US patents protecting this investigational drug and forty-three international patents.
Recent Clinical Trials for Norketamine
|The Role of HNKs in the Antidepressant Effect of Ketamine||Columbia University||Phase 1|
|Acute Pain Management in Patients on Opioid Replacement Therapy||University of California, San Francisco||Phase 1|
|Inhaled Nebulised S(+)-Ketamine for Postoperative Analgesia||Tampere University Hospital||Phase 4|
Top disease conditions for Norketamine
Top clinical trial sponsors for Norketamine
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Norketamine||See Pricing||Ketamine derivatives||Auckland Uniservices Limited (Auckland, NZ)||See Pricing|
|Norketamine||See Pricing||Neuro-attenuating ketamine and norketamine compounds, derivatives thereof, and methods||Amorsa Therapeutics, Inc. (Littleton, MA)||See Pricing|
|Norketamine||See Pricing||Assay for methoxetamine||Randox Laboratories Ltd. (GB)||See Pricing|
|Norketamine||See Pricing||Ketamine analogues for treatment of thrombocytopenia||Genentech, Inc. (South San Francisco, CA)||See Pricing|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|